Controversies in the use of postnatal steroids

Seminars in Perinatology

Volumn 25, Issue 6, 2001, Pages 397-405

  Kennedy, Kathleen A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; HYDROCORTISONE; LUNG SURFACTANT; STEROID;

ARTIFICIAL VENTILATION; CAREGIVER; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INFECTION; INTENSIVE CARE; INTESTINE PERFORATION; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEUROLOGIC DISEASE; POSTNATAL CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STEROID THERAPY; VERY LOW BIRTH WEIGHT;

EID: 0035210496     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2001.29034     Document Type: Article

References (31)

1. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996
2. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period
3. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia
4. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia
5. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
6. Variations in practice and outcomes in the Canadian NICU Network: 1996- 1997
7. Postnatal steroids: Short-term gain, long-term pain?
8. Early dexamethasone therapy in preterm infants: A follow-up study
9. Glucocorticoids in perinatal medicine: Misguided rockets?
10. Early (< 96 hours) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
11. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
12. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review)
13. Users' Guide to the medical literature: XX. Integrating research evidence with the care of the individual patient
14. Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function
15. Early versus late identification of infants at high risk of developing moderate to severe bronchopulmonary dysplasia
16. Risk factors for chronic lung disease in the surfactant era: A North Carolina population-based study of very low birth weight infants
17. An evidence based approach to individualizing treatment
18. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment
19. Early prediction of neonatal chronic lung disease: A comparison of three scoring methods
20. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCT's
21. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants
22. Clinical trials of postnatal corticosteroids: Inhaled and systemic
23. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Cochrane Review)
24. Strategies for prevention of neonatal chronic lung disease
25. Adverse effects of early dexamethasone treatment in extremely-low-birthweight infants
26. Postnatal steroids in very preterm infants: The good, the bad, and the ugly?
27. Self-perceived health status and health-related quality of life of extremely low-birth-weight infants at adolescence
28. Parental perspectives of the health status and health-related quality of life of teen-aged children who were extremely low birth weight and term controls